Emerging approaches to target mitochondrial apoptosis in cancer cells

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Apoptosis is a conserved process for cell elimination, regulated by Bcl-2 family proteins at the mitochondria.
• The balance of pro- and anti-apoptotic proteins is critical for cell death thresholds and is often dysregulated in cancer.
• Tumor cells exhibit complex resistance to apoptosis, a key hallmark of cancer progression.

Purpose of the Study:

• To review the nuanced regulation of apoptosis in cancer.
• To discuss how understanding apoptosis control has informed new therapeutic strategies.
• To highlight the mechanisms and limitations of novel apoptosis-targeting drugs like BH3-mimetics.

Main Methods:

• Literature review of apoptosis regulation in cancer.
• Analysis of the role of Bcl-2 family proteins in cell death.
• Discussion of therapeutic approaches targeting apoptosis.

Main Results:

• Dysregulation of the Bcl-2 protein balance contributes to cancer cell survival.
• BH3-mimetics represent a new class of drugs directly targeting apoptosis.
• Current understanding of apoptosis has limitations that impact therapeutic efficacy.

Conclusions:

• Targeting apoptosis is a viable strategy for cancer therapy.
• BH3-mimetics offer a promising approach to overcome cancer cell resistance to apoptosis.
• Further research is needed to fully elucidate apoptosis regulation and optimize therapeutic outcomes.